Preliminary studies show conolidine may possibly inhibit particular ion channels, minimizing neuronal excitability and limiting pain signals. This mechanism is particularly suitable in neuropathic suffering, in which irregular signaling results in persistent discomfort. Furthermore, conolidine appears to influence G protein-coupled receptor (GPCR) pathways integral to ache perception.... https://jamesw950uso0.jts-blog.com/profile